Grants and Contributions:
Title:
Development of Screening Test for Genetic Hereditary CRC
Agreement Number:
925745
Agreement Value:
$43,400.00
Agreement Date:
Apr 1, 2019 - Dec 31, 2019
Description:
VastCon has discovered unique molecular signatures in blood that could detect genetic hereditary colorectal cancers. This project is aimed at developing a screening test for genetic hereditary colorectal cancer.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Winnipeg, Manitoba, CA R3Y 0A2
Reference Number:
172-2019-2020-Q1-925745
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
810234633
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 91 days. The total amended value is 43,398 dollars.
Amendment Date
Sep 16, 2019
Recipient's Legal Name:
Vastcon Inc.
Federal Riding Name:
Winnipeg South
Federal Riding Number:
46013
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
33911
Amendments: